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Abstract
Background: The aims of this systematic review and meta-analysis of randomized controlled trials are to evaluate
the effects of active heated humidifiers (HHs) and moisture exchangers (HMEs) in preventing artificial airway
occlusion and pneumonia, and on mortality in adult critically ill patients. In addition, we planned to perform a
meta-regression analysis to evaluate the relationship between the incidence of artificial airway occlusion,
pneumonia and mortality and clinical features of adult critically ill patients.
Methods: Computerized databases were searched for randomized controlled trials (RCTs) comparing HHs and
HMEs and reporting artificial airway occlusion, pneumonia and mortality as predefined outcomes. Relative risk (RR),
95% confidence interval for each outcome and I2 were estimated for each outcome. Furthermore, weighted
random-effect meta-regression analysis was performed to test the relationship between the effect size on each
considered outcome and covariates.
Results: Eighteen RCTs and 2442 adult critically ill patients were included in the analysis. The incidence of artificial
airway occlusion (RR = 1.853; 95% CI 0.792–4.338), pneumonia (RR = 932; 95% CI 0.730–1.190) and mortality (RR = 1.023;
95% CI 0.878–1.192) were not different in patients treated with HMEs and HHs. However, in the subgroup analyses
the incidence of airway occlusion was higher in HMEs compared with HHs with non-heated wire (RR = 3.776; 95%
CI 1.560–9.143). According to the meta-regression, the effect size in the treatment group on artificial airway occlusion
was influenced by the percentage of patients with pneumonia (β = -0.058; p = 0.027; favors HMEs in studies with high
prevalence of pneumonia), and a trend was observed for an effect of the duration of mechanical ventilation (MV)
(β = -0.108; p = 0.054; favors HMEs in studies with longer MV time).
Conclusions: In this meta-analysis we found no superiority of HMEs and HHs, in terms of artificial airway
occlusion, pneumonia and mortality. A trend favoring HMEs was observed in studies including a high percentage
of patients with pneumonia diagnosis at admission and those with prolonged MV. However, the choice of
humidifiers should be made according to the clinical context, trying to avoid possible complications and
reaching the appropriate performance at lower costs.
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Background
Mechanical ventilation (MV) suppresses the mechanisms
that heat and moisturize inhaled air. As a consequence,
the lack of adequate conditioning may thicken airway se-
cretions, which increases the airway resistance, reduces
the gas exchange effectiveness and increases the risk of
respiratory infections [1]. For these reasons, gas delivered
during MV must be warmed and humidified to avoid
serious complications related to dry gases [2]. To date, hu-
midification devices can be divided into active heated hu-
midifiers (HHs), which are devices heated by warm water,
and passive devices such as heat and moisture exchangers
(HMEs), which capture the heat of exhaled air and release
it at the next inspiration [3]. HHs may result in increased
airway hydration, decreased incidence of bacterial infec-
tion and work of breathing, while HMEs may increase the
risk of airway occlusion [4]. In clinical practice, humidifi-
cation during MV is widely accepted and applied; however,
there is lack of consensus on the optimal device to humid-
ify the airways. The aims of this systematic review and
meta-analysis of randomized controlled trials are to evalu-
ate the effects of HMEs and HHs in preventing artificial
airway occlusion and pneumonia, and on mortality in
adult critically ill patients. We planned a priori a sub-
analysis stratifying the studies according to the type of
HH, hypothesizing that HHs with heated wire could
perform differently from those with non-heated wire.
In addition, we planned to perform a meta-regression
analysis to evaluate the relationship between the incidence
of artificial airway occlusion, pneumonia and mortality
and clinical features of adult critically ill patients.
Methods
Data sources and searches
We aimed to identify all randomized controlled trials
(RCTs) comparing HMEs and HHs in adult critically ill
patients. We applied standard filters for the identifica-
tion of RCTs using the MEDLINE and PUBMED search
engines (from inception to June 2014), using English lan-
guage restrictions. Our search included the following
keywords: heat and moisture exchangers, heated humidi-
fiers, airway humidification, artificial humidification,
artificial airway occlusion, mortality, pneumonia and
humans and randomized clinical trial.
Selection of studies
Trials comparing any type of HH, including systems
with heated and non-heated wire, with HMEs in adult
critically ill patients were included. We restricted the
analysis to RCTs to guarantee control of selection bias.
We included only published full papers and excluded ab-
stracts. Study designs containing inadequately adjusted
planned co-interventions and crossover trials were ex-
cluded. The intervention of interest was the use of HH and
HME in reducing artificial airway occlusion, pneumonia
and mortality. Studies were further divided according to the
use of HH with heated and HH with non-heated wire to
perform the subgroup analysis.
Outcome measures
The primary outcome was the incidence of artificial airway
occlusion; the secondary outcomes were the incidences of
pneumonia and mortality.
Data extraction and quality assessment
Initial selection was performed by two pairs of inde-
pendent reviewers (MV and DC, PP and YS) screening
titles and abstracts. For detailed evaluation, a full-text
copy of all studies of possible relevance was retrieved.
Data from each study were extracted independently by
paired and independent reviewers (LB and DC, PP and
YS) using a standardized data abstraction form. Data
extracted from the publications were independently
checked for accuracy by two other reviewers (GS and
AE). Quality assessment of these studies included: (1)
use of randomization sequence generation, (2) report-
ing and type of allocation concealment, (3) blinding, (4)
reporting of incomplete outcome data and (5) compar-
ability of the groups at baseline. Quality assessment is
reported in Additional file 1. Two reviewers (MV and
LB) independently used these criteria to evaluate trial
quality. We solved any possible disagreement by con-
sensus in consultation with two other reviewers (GS
and AE) if needed.
Qualitative analysis
A narrative summary approach was used to explore
study characteristics and quality indicators in describing
variation among studies and to consider possible impli-
cations for this in our understanding of the outcomes of
the RCTs included in the Cochrane review [5, 6].
Quantitative analysis
The meta-analysis was conducted according to the
Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guidelines [7]. Meta-analysis
was performed with mixed random effect using the
DerSimonian and Laird method. Results were graphically
represented using forest plot graphs. The relative risk (RR)
and 95% CI for each outcome were separately calculated
for each trial, pooling data when needed, according to an
intention-to-treat principle. The choice to use RRs was
driven by the design of meta-analysis based on RCTs. Tau2
was used to define the variance between studies. The dif-
ference in the estimates of treatment effect between the
treatment groups for each hypothesis was tested using the
two-sided z test with statistical significance considered at
p value <0.05. The homogeneity assumption was checked
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with the Q test with a degree of freedom (df) equal to the
number of analyzed studies minus 1. The heterogeneity
was measured by the I2 metric, which describes the per-
centage of total variation across studies that is due to het-
erogeneity rather than chance. I2 was calculated as:
I2 = 100% Å ~ (Q − df)/Q
where Q is Cochran’s heterogeneity statistic and df is de-
grees of freedom. A value of 0% indicates no observed
heterogeneity, and larger values show increasing hetero-
geneity. We decided a priori to analyze all the outcomes
according to the following categories when possible:
HME vs HH, HME vs HH with heated wire and HME vs
HH with non-heated wire.
Weighted random-effect meta-regression analysis was
performed to test the relationship between the effect size
on each considered outcome and the following covari-
ates, with each one analysed separately: duration of MV,
pneumonia incidence, intensive care unit (ICU) length
of stay, percentage of respiratory diagnoses at ICU ad-
mission, simplified acute physiology score (SAPS), age
and acute physiology and chronic health evaluation II
(APACHE II) score.
Analyses were conducted with OpenMetaAnalyst (ver-
sion 6) and SPSS version 20 (IBM SPSS). Weighted lin-
ear regression was used to evaluate potential publication
bias, with the natural log of the RR as the dependent
variable and the inverse of the total sample size as the
independent variable. This is a modified Macaskill test
that gives more balanced type I error rates in the tail
probability areas in comparison to other publication bias
tests [8].
Results
Study selection
We identified 1349 references and excluded 1266 after
screening titles and abstracts. We analyzed 77 articles in
full paper format. We excluded 59 references [9–65] and
18 references fulfilled our search criteria [66–83]. Figure 1
shows the study selection process.
Characteristics of included studies
These 18 RCTs included 2442 adult critically ill patients.
The main characteristics of the included studies are re-
ported in Table 1.
Systematic errors of included studies
None of the included trials had a low risk of bias. The
random sequence generation was adequate in seven
studies [75, 78–83], adequate allocation concealment was
present in three studies [77–79] and adequate blinding was
present in two studies [75, 76]. Complete outcome data
were reported from 10 studies [66–70, 73–76, 80–83]. Ten
studies reported no imbalance in baseline characteristics
[66–71, 73, 76, 79, 81]. The quality assessment for each
RCT is reported in Additional file 1.
Primary outcome
The incidence of artificial airway occlusion was not dif-
ferent in patients treated with HMEs and HHs (Fig. 2)
(RR = 1.853; 95% CI 0.792–4.338). Artificial airway oc-
clusion incidence was not different when comparing
HMEs with HHs with heated wire (RR = 0.379; 95% CI
0.140–1.384) (Fig. 3, upper panel). However, airway oc-
clusion was higher with HMEs compared with HHs with
non-heated wire (RR = 3.776; 95% CI 1.560–9.143) (Fig. 3,
lower panel), but there were no differences between
hydrophobic and hygroscopic HMEs compared with
HHs (Additional file 2).
Secondary outcomes
The incidence of pneumonia was not different in pa-
tients treated with HMEs and HHs (Fig. 4) (RR = 932;
95% CI 0.730–1.190). Incidence of pneumonia was not
different when comparing HMEs and HHs with heated
wire (RR = 0.997; 95% CI 0.642–1.548), with significant
inhomogeneity (I2 = 54%; p = 0.042) (Fig. 5, upper panel),
neither was it different with HHs with non-heated wire
(RR = 0.756; 95% CI 0.479–1.193) (Fig. 5, lower panel).
Mortality was not different in patients treated with
HMEs and HHs (Fig. 6, upper panel) (RR = 1.023; 95%
CI 0.878–1.192). Mortality was comparable in patients
treated with HMEs and HHs with heated wire (RR =
0.947; 95% CI 0.723–1.241) (Fig. 6, middle panel). We did
not find differences in mortality when comparing HMEs
and HHs with non-heated wire (RR = 1.186; 95% CI
0.852–1.650) (Fig. 6, lower panel).
1347 references fulfilled 
search
77 references reviewed in 
full paper format
59 references were excluded
18 references included
1266 references were 
excluded after reading 
title and abstract
Fig. 1 The study selection process
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Fig. 2 Artificial airway occlusion comparing the heat and moisture exchanger (HME) with the heated humidifier (HH). Weights: Kirkegaard 6.8%,
Martin 7.1%, Misset 15.3%, Roustan 7.1%, Dreyfuss 5.9%, Branson 4.2%, Villafane 10.7%, Boots (2006) 4.2%, Hurni 5.9%, Kirton 6.6%, Kollef 4.1%,
Lucchetti 6.9%, Lacherade 10.8%, boots (1997) 4.1%
Fig. 3 Upper box artificial airway occlusion comparing the heat and moisture exchanger (HME) and the heated humidifier (HH) with heated wire. Weights:
Branson 11%, Boots (1997) 11%, Kirton 19.2%, Kollef 11%, Lacherade 36.8% Boots (2006) 10.9%. Lower box artificial airway occlusion comparing HME and
HH with non-heated wire. Weights: Kirkegaard 8.9%, Martin 9.7%, Misset 30%, Roustan 9.8%, Dreyfuss 7.7%, Villafane 16.8%, Hurni 7.7%, Lucchetti 9.3%
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Meta-regression analysis
The effect size in the treatment group on artificial air-
way occlusion was influenced by the percentage of pa-
tients with pneumonia included in the study (β = -0.058;
p = 0.027; favoring HMEs in studies with high prevalence
of pneumonia), and a trend was observed for the duration
of MV (β = -0.108; p = 0.054; favoring HMEs in studies with
longer MV time) (Fig. 7). No other significant associations
with the effect size on any outcome measure were observed
for the other clinical variables (see Additional file 3).
Fig. 4 Incidence of pneumonia comparing the heat and moisture exchanger (HME) with the heated humidifier (HH). Weights: Martin 2.5%,
Roustan 4.7%, Dreyfuss 5%, Branson 2.3%, Boots (1997) 5%, Kirton 8.6%, Kollef 9.1%, Memish 9.4%, Diaz 5.5%, Lacherade 19.5%, Lorente 8.4%,
Boots (2006) 14.3%, Oguz 5.1%
Fig. 5 Upper panel: incidence of pneumonia comparing the heat and moisture exchanger (HME) and the heated humidifier (HH) with heated
wire. Weights: Branson 5.7%, Boots (1997) 9.3%, Kirton 15%, Kollef 15.7%, Lachede 22%, Lorente 12.6%, Boots (2006) 19.7%. Lower panel incidence
of pneumonia comparing HME and HH with non-heated wire. Weights: Martin 7.8%, Roustan 15.5%, Dreyfuss 16.7%, Memish 37.9%, Diaz 11.8%,
Oguz 10.2%
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Discussion
In this systematic review and meta-analysis, we found:
(1) no significant difference in artificial airway occlusion,
pneumonia or mortality between HMEs and HHs, (2) no
effect of HHs with and without heated wire compared to
HMEs; however HHs with non-heated wire had the
lower RR for artificial airway occlusion compared with
HME, and (3) independently from the HH type, an ad-
vantage of HMEs in airway occlusion incidence was ob-
served in studies with high incidence of pneumonia, and
a trend toward favoring HMEs was observed for studies
with prolonged MV. To our knowledge, this is the first
systematic review performed (1) by dividing RCTs
according to HHs with heated and non-heated wire and
(2) including a meta-regression analysis on the potential
effects of clinical variables on the efficacy of the two
devices.
According to the American Association for Respira-
tory Care (AARC) guidelines, HHs should provide an
absolute humidity level of between 33 and 44 mgH2O/L,
whereas HMEs should provide a minimum humidity
level of 30 mgH2O/L [1]. HHs may produce insufficient
heat and humidification when the temperature is im-
properly selected or pre-set at a non-adjustable level ra-
ther than at the clinical setting [1]. However, insufficient
heat and humidification may occur with HMEs too [1].
Fig. 6 Upper panel mortality comparing the heat and moisture exchanger (HME) with the heated humidifier (HH). Weights: Kirkegaard1%, Martin
3.4%, Roustan 4.6%, Dreyfuss 5.4%, Boots (1997) 1.6%, Hurni 7.9%, Kollef 16.1%, Memish 14.5%, Diaz 2.6%, Lacherade 28.3%, Boots (2006) 14.4%.
Middle panel mortality comparing HME and HH with heated wire. Weights: Boots (1997) 4%, Boots (2006) 28.9%, Kollef 27.9%, Lacherade 39.2%.
Lower box mortality comparing HME and HH with non-heated wire. Weights: Diaz 6.2%, Dreyfuss 15.6%, Hurni 17.51%, Kirkegaard 3.1%, Martin
9.2%, Memish 34.9%, Roustan 13.5%
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Only 37% of HMEs have been found to meet the stand-
ard criteria advocated by the AARC guidelines [1]. Insuf-
ficient airway humidification may lead to an increase in
tracheal tube occlusion, a serious adverse event that may
occur in mechanically ventilated patients and requires
timely intervention. In an RCT comparing HMEs and
HHs with increasing minute ventilation, the authors
found that after 72 hours the inner diameter of the
endotracheal tube decreased by 2.5–6.5 mm when gas
conditioning was performed using HMEs and by 1.5 mm
with HHs [72]. A systematic review showed that in pa-
tients ventilated more than 48 hours, there is no differ-
ence in tracheal tube occlusion when comparing HMEs
and HHs [84]. In this meta-analysis, we found no differ-
ences in the incidence of artificial airway occlusion, but
stratifying the comparison according to the type of HHs we
found less risk for airway occlusion in HHs without heated
wire compared with HME. However, these data were not
confirmed by the sub-analysis comparing hydrophobic and
hygroscopic HMEs with HHs. Probably, the main deter-
minants of artificial airway occlusion are the duration
of mechanical ventilation and pneumonia, rather than
humidifier type per se, even if a prolonged use of HME
(<72 hours) may increase this risk. Long-term invasive
MV and the presence of ventilator-associated pneumonia
(VAP) increased the risk of artificial airway occlusion
threefold in one study [85] and twofold in another [86].
This is the first meta-analysis reporting a meta-regression
of included studies in this field. Our meta-regression
showed that in studies with high incidence of pneumonia
and prolonged MV, the HMEs had a slight advantage in
terms of the artificial airway occlusion.
Earlier models of HME were associated with an in-
creased incidence of airway occlusion, which led to the
exclusion of patients at high risk from the studies [86].
In contrast, trials using HMEs with enhanced intrinsic
humidifying performance showed no difference in the
incidence of airway occlusion [86]. A Cochrane review
states that hydrophobic HMEs may reduce the risk of
pneumonia and the use of an HME may increase artifi-
cial airway occlusion in certain subgroups of patients [4].
Our analysis includes more recently published studies. Ac-
cording to our meta-regression, the HME may reduce the
risk of airway occlusion in selected patients affected by
pneumonia.
Hess et al. concluded in their clinical practice guide-
lines that HMEs are associated with lower incidence of
pneumonia compared with HHs [85]. However, there are
concerns about the increased airway resistance and care
of HME filters [85]. Kola et al. found a significant reduc-
tion in pneumonia using HMEs during MV, particularly
when patients are ventilated for 7 days or more [86].
Hess et al. included studies published between 1990 and
1998 in their analysis of pneumonia [85]. Kola et al. re-
ported the same results as Hess et al. but they only included
one more study in their meta-analysis. Accordingly, the
underlying mechanism of reduction in pneumonia may be
due to the dryness of the ventilator circuit when using
HMEs [85, 86]. Therefore, HMEs minimized the need for
septic manipulations or aspirations of the airway/circuit
and the circuit condensate [85, 86]. Furthermore, the inclu-
sion of more recent studies may have changed the results.
Indeed, Siempos et al. did not find any superiority of HMEs
compared to HHs in reducing pneumonia, mortality or
morbidity [87]. The results of Siempos et al. were ground-
breaking and in line with the RCTs published at that time.
The inclusion of three further RCTs [80–82] with 870 pa-
tients dramatically changed the previous results. The
Cochrane review by Kelly et al. included adult and pediatric
patients treated with HMEs and HHs [4]. There was no
overall effect on artificial airway occlusion, mortality, pneu-
monia or respiratory complications; however, the arterial
partial pressure of carbon dioxide (PaCO2) and minute ven-
tilation were increased while body temperature was lower
when HMEs were compared to HHs [4] in a meta-analysis
including 18 RCTs and 2442 adult critically ill patients. In
line with the available literature, we did not find any differ-
ence in artificial airway occlusion, pneumonia or mortality
Fig. 7 Meta-regression on artificial airway occlusion including duration of mechanical ventilation (β = 2.637; p = 0.054) and pneumonia (β = 1.794;
p = 0.012) as covariate. HME heat and moisture exchanger, HH heated humidifier
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between HMEs and HHs, even if according to their nature,
they have different characteristics. However, HMEs were
found to increase the PaCO2 and work of breathing prob-
ably due to higher dead space, and to reduce the inner
diameter of the endotracheal tube during prolonged MV
[4]. Indeed, HME may negatively impact on ventilator func-
tion while increasing the dead space [11]. In spontaneously
and assisted breathing patients, this requires increased mi-
nute ventilation and then the work of breathing, to main-
tain constant alveolar ventilation and PaCO2. In controlled
MV, the additional dead space of HMEs may reduce alveo-
lar ventilation and increase PaCO2 [11]. This effect of HME
dead space may be further exacerbated by protective venti-
lation at low tidal volume (VT) and by using HMEs with a
larger dead space [11].
Humidification is mandatory during MV. Nowadays,
the airway humidification is appropriate in the absence
of any contraindications listed by the AARC guidelines,
such as altered body temperature, airway thermal injury,
under hydrated secretions, increased work of breathing,
hypoventilation, condensation and airway dehydration
[1]. Clear advantages in terms of clinical outcomes for
different humidification devices are far from being dem-
onstrated. The present meta-analysis reported no super-
iority of HMEs over HHs in term of clinical outcomes,
with similar results even when stratifying the studies ac-
cording to the type of HH, while some advantage of
HMEs might be possible in patients with pneumonia or
those with a long MV time. The choice of humidifiers
should be made according to the clinical context trying
to avoid possible complications and reaching the appropri-
ate performance at lower costs. However, to help clinicians
make the correct choice between HHs and HMEs, further
high-quality RCTs are needed to evaluate the incidence of
respiratory complications other than pneumonia, gas ex-
change and work of breathing when comparing the HH
and HME devices.
This systematic review and meta-analysis has several
limitations that must be addressed. First, the quality of
the included RCTs was relatively low and our conclu-
sions may be limited by this point. Second, the diagnosis
of pneumonia was differently defined across the studies
and often mixed with VAP. Third, the definition of mor-
tality varied between the studies: three studies reported
the ICU mortality, two studies reported overall mortal-
ity, two studies reported hospital mortality, one studies
reported mortality during MV and in four studies mor-
tality was not reported. Fourth, we performed the meta-
analyses of outcomes if reported by more than three
RCTs. Fifth, as we found only one additional RCT pub-
lished between 2006 and 2013, the present results may
depend on the studies published before 2006. However,
in contrast to previous reports we included a meta-
regression analyzing and interpreting data from a new
point of view. Sixth, we found few studies reporting the
effective tracheal tube lumen and most of them with
provided a poor definition of pneumonia diagnosed at
ICU admission. Seventh, we are not able to stratify the
meta-analysis according to the baseline respiratory con-
dition or inclusion criteria. This did not allow us to sug-
gest the use of HMEs or HHs in different respiratory
diseases.
New, prospective RCTs are needed in terms of assessing
the effect of HHs vs HMEs in patients with respiratory
failure due to pneumonia, on airway diameter, the amount
of secretion and the occurrence of artificial airway ob-
struction and VAP.
Conclusions
In this meta-analysis including 18 RCTs and 2442 adult
critically ill patients, we found no superiority of HMEs
or HHs, in terms of artificial airway occlusion, pneumonia
and mortality. These results were also confirmed in the
sub-analysis dividing HHs into heated and non-heated
wire devices. However, HHs with non-heated wire had the
lower RR for artificial airway occlusion compared with
HMEs. A trend favoring HMEs was observed in studies in-
cluding a high percentage of patients with pneumonia
diagnosis at admission and those with prolonged MV.
However, the choice of humidifiers should be made ac-
cording to the clinical context, trying to avoid possible
complications and reaching the appropriate performance
at lower costs.
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